Random thoughts on « AI » and Free Software

IA : le plan du gouvernement pour développer et réguler l’intelligence artificielle dans la fonction publique

Le gouvernement a présenté, mardi 16 juin, un « plan pour une IA utile, humaine et souveraine pour le service public ». Plusieurs outils vont être généralisés au sein de l’administration. Une « négociation sociale » sera aussi lancée, jeudi 18 juin, pour encadrer l’usage de cette technologie.

NVIDIA SkillSpector Guide: Scanning AI Skills for Security Risks with Static Analysis and SARIF Reports

SkillSpector scans AI skills for risks using static analysis, custom detectors, risk visualization, and SARIF reporting before deployment.

Towards Conversational AI for Disease Management - Nature

While large language models (LLMs) have shown promise in diagnostic dialogue1, their capabilities for effective management reasoning—including disease progression, therapeutic response, and safe medication prescription—remain under-explored. We advance the previously demonstrated diagnostic capabilities of the Articulate Medical Intelligence Explorer (AMIE)1−3 through a new LLM-based agentic system optimized for multi-visit clinical management and dialogue. To ground its reasoning in authoritative clinical knowledge, AMIE leverages Gemini’s long-context capabilities4, combining in-context retrieval with structured reasoning to align its output with up-to-date clinical practice guidelines and drug formularies. In a randomized, blinded virtual Objective Structured Clinical Examination (OSCE) study, AMIE was compared to 21 primary care physicians (PCPs) across 100 multi-visit case scenarios designed to reflect UK NICE Guidance and BMJ Best Practice guidelines. AMIE was non-inferior to PCPs in management reasoning as assessed by specialists and scored better in both preciseness of treatments and investigations, and in its alignment with and grounding in clinical guidelines. To benchmark medication reasoning, we developed RxQA, a multiple-choice question benchmark derived from two national drug formularies (US, UK) and validated by board-certified pharmacists. Though AMIE and PCPs both benefited from the ability to access external drug information, AMIE outperformed PCPs on higher difficulty questions. While further research would be needed before real-world translation, AMIE’s strong performance across evaluations marks a significant step towards conversational AI as a tool in disease management.

Americans and AI 2026: Chatbots, Smart Devices and Views on Impact

More Americans are using chatbots, and some are adopting AI summaries and smart speakers. But views about AI and how fast it’s advancing tilt negative – even for younger adults.